Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations – Special focus on KRAS G12C 5. November 2020 Griesinger F, Eberhardt WEE, Hoffnecht P, Metzenmacher M, Wehler T, Kokowski K, Alt J, Schütte W, Jänicke M, Fleitz A, Zacharias S, Hipper A, Buller M, Weichert W, Groschek M, von der Heyde E, Rauh J, Dechow T, Sebastian M, Thomas M, 2020 Oncol Res Treat. 2020;43 (suppl 4)(239):135 https://www.iomedico.com/wp-content/uploads/2020/11/Griesinger_CRISP_DGHO2020.mp4